FOLH1 and prostate carcinoma: Recently, Ga-68 labeled (Glu-NH-CO-NH-Lys-(Ahx)-[Ga-68(HBED-CC)] prostate-specific membrane antigen (PSMA) PET/CT has emerged as a more promising imaging modality in prostate cancer detection.